Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
Close (04-30-2024) |
$32.10 |
|---|---|
| Change |
$0.00
(0.00%)
|
| Open | - |
|---|---|
| Day Range | - - - |
| Volume | 0 |
As at March 31, 2024
As at March 31, 2024
As at February 29, 2024
Loading...
Loading...
Inception Return (April 26, 2022): -8.50%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -0.78% | 7.22% | 18.86% | 7.22% | 4.14% | - | - | - | - | - | - | - | - | - |
| Benchmark | 4.14% | 6.62% | 15.26% | 6.62% | 13.96% | 3.95% | 9.11% | 16.99% | 9.96% | 9.65% | 8.48% | 9.70% | 7.76% | 7.67% |
| Category Average | 1.75% | 21.53% | 21.53% | 10.46% | 26.42% | 7.93% | 5.18% | 15.21% | 11.07% | 11.30% | 11.63% | 12.17% | 10.44% | 11.78% |
| Category Rank | 174 / 198 | 130 / 197 | 87 / 193 | 130 / 197 | 151 / 177 | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 4 | 3 | 2 | 3 | 4 | - | - | - | - | - | - | - | - | - |
| Return % | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 0.97% | 1.89% | -4.74% | 2.26% | -3.30% | -9.59% | -8.89% | 11.39% | 9.24% | -2.07% | 10.34% | -0.78% |
| Benchmark | 2.90% | -4.95% | 3.36% | 2.58% | -1.37% | -3.33% | -3.21% | 7.48% | 3.91% | 0.55% | 1.82% | 4.14% |
11.39% (November 2023)
-10.13% (December 2022)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | - | -10.47% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | 4 |
| Category Rank | - | - | - | - | - | - | - | - | - | 163/ 168 |
-10.47% (2023)
-10.47% (2023)
| Name | Percent |
|---|---|
| US Equity | 69.97 |
| International Equity | 28.94 |
| Canadian Equity | 1.10 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Healthcare | 99.64 |
| Other | 0.36 |
| Name | Percent |
|---|---|
| North America | 71.07 |
| Europe | 20.13 |
| Asia | 8.45 |
| Other | 0.35 |
| Name | Percent |
|---|---|
| Sarepta Therapeutics Inc | 5.41 |
| Moderna Inc | 4.71 |
| Revolution Medicines Inc | 4.65 |
| Merck & Co Inc | 4.50 |
| GSK plc | 4.20 |
| Regeneron Pharmaceuticals Inc | 4.16 |
| Exelixis Inc | 3.82 |
| Sanofi SA | 3.73 |
| Incyte Corp | 3.72 |
| Iovance Biotherapeutics Inc | 3.58 |
| Standard Deviation | - | - | - |
|---|---|---|---|
| Beta | - | - | - |
| Alpha | - | - | - |
| Rsquared | - | - | - |
| Sharpe | - | - | - |
| Sortino | - | - | - |
| Treynor | - | - | - |
| Tax Efficiency | - | - | - |
| Volatility | - | - | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | - | - | - | - |
| Beta | - | - | - | - |
| Alpha | - | - | - | - |
| Rsquared | - | - | - | - |
| Sharpe | - | - | - | - |
| Sortino | - | - | - | - |
| Treynor | - | - | - | - |
| Tax Efficiency | - | - | - | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | April 26, 2022 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | - |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $5 |
| 52 Week High | $34.90 |
| 52 Week Low | $24.92 |
| Annual Dividend | $0.08 |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
| Exposure | - |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
XDNA seeks to provide long-term capital growth by replicating, to the extent possible, the performance, net of expenses, of an Index selected at the discretion of BlackRock Canada that is composed of securities of issuers that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering, as determined by the Index Provider. XDNA currently seeks to replicate the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index.
XDNA’s current principal investment strategy is to employ a Replicating Strategy. In addition to or as an alternative to this strategy, XDNA may also invest by employing a Sampling Strategy, by investing in one or more iShares ETFs and/or through the use of derivatives.
| Name | Start Date |
|---|---|
| BlackRock Asset Management Canada Limited | 03-31-2022 |
| Fund Manager | BlackRock Asset Management Canada Limited |
|---|---|
| Advisor | BlackRock Asset Management Canada Limited |
| Custodian | - |
| Registrar | - |
| Distributor | - |
| Auditor | PricewaterhouseCoopers |
| MER | 0.44% |
|---|---|
| Management Fee | 0.39% |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
